Cell Line | Total Dose | Number of Fractions | α/β before treatment | α/β end of streatment | SF2 before treatment | SF2 end of treatment |
---|---|---|---|---|---|---|
PC3 31 | 10 Gy | 5 | 22.1 ± 7.0 Gy | 16.6 ± 6.2 Gy | 0.40 ± 0.09 | 0.50 ± 0.10 |
LNCaP 31 | 10 Gy | 5 | 18.0 ± 6.5 Gy | 12.5 ± 5.9 Gy | 0.47 ± 0.10 | 0.58 ± 0.12 |
Du145 31 | 10 Gy | 5 | 15.5 ± 6.3 Gy | 10.1 ± 5.5 Gy | 0.52 ± 0.11 | 0.64 ± 0.12 |
A549 32 | 16 Gy | 8 | 10.2 ± 3.3 Gy | 5.4 ± 2.7 Gy | 0.44 ± 0.10 | 0.61 ± 0.11 |
H460 32 | 26 Gy | 13 | 3.1 ± 1.1 Gy | 1.2 ± 0.8 Gy | 0.46 ± 0.08 | 0.61 ± 0.07 |
OE33 30 | 50 Gy | 25 | 20.6 ± 5.1 Gy | 13.7 ± 3.2 Gy | 0.42 ± 0.05 | 0.56 ± 0.04 |